Rachel I. Gafni

Pediatric Endocrinology

30 Rockville Pike
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

PTH-Independent CaSR Inhibition with the Oral Calcilytic Encaleret Improves Calcium Homeostasis in Post-Surgical Hypoparathyroidism: A Phase 2 Open-Label Proof-of-Concept Trial.

PTH-Independent CaSR Inhibition with the Oral Calcilytic Encaleret Improves Calcium Homeostasis in Post-Surgical Hypoparathyroidism: A Phase 2 Open-Label Proof-of-Concept Trial.

Journal: Research square

Published: May 25, 2026

PTH-Independent CaSR Inhibition with the Oral Calcilytic Encaleret Improves Calcium Homeostasis in Post-Surgical Hypoparathyroidism: A Phase 2 Open-Label Proof-of-Concept Trial.

PTH-Independent CaSR Inhibition with the Oral Calcilytic Encaleret Improves Calcium Homeostasis in Post-Surgical Hypoparathyroidism: A Phase 2 Open-Label Proof-of-Concept Trial.

Journal: Research square

Published: May 25, 2026

Burosumab treatment in an adult with FGF23-mediated hypophosphatemia due to cutaneous skeletal hypophosphatemia syndrome.

Burosumab treatment in an adult with FGF23-mediated hypophosphatemia due to cutaneous skeletal hypophosphatemia syndrome.

Journal: Journal of the Endocrine Society

Published: October 19, 2025

Phenotypic characterization of ENPP1 deficiency: generalized arterial calcification of infancy and autosomal recessive hypophosphatemic rickets type 2.

Phenotypic characterization of ENPP1 deficiency: generalized arterial calcification of infancy and autosomal recessive hypophosphatemic rickets type 2.

Journal: JBMR plus

Published: November 07, 2024

Jansen metaphyseal chondrodysplasia: analysis of craniofacial manifestations.

Jansen metaphyseal chondrodysplasia: analysis of craniofacial manifestations.

Journal: JBMR plus

Published: July 18, 2024

Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis.

Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 25, 2024

Ocular findings in Jansen metaphyseal chondrodysplasia.

Ocular findings in Jansen metaphyseal chondrodysplasia.

Journal: JBMR plus

Published: April 09, 2024

Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis.

Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: November 22, 2023

Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1.

Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1.

Journal: The New England journal of medicine

Published: September 27, 2023

Atypical Fragility Fractures due to Bony or Soft Tissue Phosphaturic Mesenchymal Tumors: A Report of Two Cases.

Atypical Fragility Fractures due to Bony or Soft Tissue Phosphaturic Mesenchymal Tumors: A Report of Two Cases.

Journal: Case reports in orthopedics

Published: June 29, 2022

Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.

Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: June 01, 2022

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.

Journal: JBMR plus

Published: April 25, 2022

Showing 1-12 of 67

Last Updated: 09/26/2026